H5N1: The strange tale of Canada’s Ebola vaccine

Via The Star, a column by Thomas Walkom: The strange tale of Canada’s ebola vaccine. Excerpt: The strange case of Canada’s Ebola vaccine became even stranger Monday. That’s when the pharmaceutical multinational Merck announced it will pay $50 million for…

Source: crofsblogs.typepad.com

See on Scoop.itVirology and Bioinformatics from Virology.ca

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.